Neuberger Berman Group’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-22,929
| Closed | -$281K | – | 2046 |
|
|
2025
Q2 | $281K | Sell |
22,929
-1,021,604
| -98% | -$12.8M | ﹤0.01% | 1754 |
|
|
2025
Q1 | $15M | Buy |
1,044,533
+67,085
| +7% | +$1.05M | 0.01% | 692 |
|
|
2024
Q4 | $15.5M | Sell |
977,448
-89,366
| -8% | -$1.77M | 0.01% | 716 |
|
|
2024
Q3 | $25.6M | Buy |
1,066,814
+68,841
| +7% | +$1.57M | 0.02% | 599 |
|
|
2024
Q2 | $19.9M | Buy |
997,973
+54,460
| +6% | +$1.06M | 0.02% | 638 |
|
|
2024
Q1 | $18.8M | Buy |
943,513
+42,831
| +5% | +$828K | 0.02% | 657 |
|
|
2023
Q4 | $20.2M | Sell |
900,682
-13,316
| -1% | -$275K | 0.02% | 616 |
|
|
2023
Q3 | $18.5M | Buy |
913,998
+10,703
| +1% | +$243K | 0.02% | 616 |
|
|
2023
Q2 | $23.1M | Sell |
903,295
-5,926
| -0.7% | -$156K | 0.02% | 580 |
|
|
2023
Q1 | $27M | Buy |
909,221
+33,334
| +4% | +$968K | 0.03% | 559 |
|
|
2022
Q4 | $23.7M | Buy |
875,887
+5,363
| +0.6% | +$131K | 0.02% | 579 |
|
|
2022
Q3 | $19M | Buy |
870,524
+44,361
| +5% | +$1.16M | 0.02% | 619 |
|
|
2022
Q2 | $22.6M | Buy |
826,163
+6,103
| +0.7% | +$175K | 0.02% | 598 |
|
|
2022
Q1 | $27.5M | Sell |
820,060
-13,333
| -2% | -$429K | 0.02% | 601 |
|
|
2021
Q4 | $28.5M | Buy |
833,393
+39,861
| +5% | +$1.29M | 0.02% | 600 |
|
|
2021
Q3 | $24.6M | Buy |
793,532
+340,905
| +75% | +$11.6M | 0.02% | 627 |
|
|
2021
Q2 | $16.4M | Sell |
452,627
-8,221
| -2% | -$340K | 0.01% | 745 |
|
|
2021
Q1 | $20M | Sell |
460,848
-27,151
| -6% | -$1.27M | 0.02% | 689 |
|
|
2020
Q4 | $22.3M | Sell |
487,999
-5,690
| -1% | -$237K | 0.02% | 613 |
|
|
2020
Q3 | $16.4M | Sell |
493,689
-7,667
| -2% | -$245K | 0.02% | 629 |
|
|
2020
Q2 | $14.7M | Buy |
501,356
+217,738
| +77% | +$6.3M | 0.02% | 635 |
|
|
2020
Q1 | $7.63M | Buy |
+283,618
| New | +$8.47M | 0.01% | 715 |
|
|
2019
Q1 | – | Sell |
-5,722
| Closed | -$256K | – | 1519 |
|
|
2018
Q4 | $256K | Hold |
5,722
| – | – | ﹤0.01% | 1414 |
|
|
2018
Q3 | $392K | Sell |
5,722
-934
| -14% | -$60.1K | ﹤0.01% | 1359 |
|
|
2018
Q2 | $386K | Sell |
6,656
-3,839
| -37% | -$203K | ﹤0.01% | 1443 |
|
|
2018
Q1 | $511K | Sell |
10,495
-5,911
| -36% | -$281K | ﹤0.01% | 1343 |
|
|
2017
Q4 | $840K | Buy |
+16,406
| New | +$754K | ﹤0.01% | 1273 |
|
|
2015
Q3 | – | Sell |
-372,708
| Closed | -$15.1M | – | 1531 |
|
|
2015
Q2 | $15.1M | Buy |
372,708
+366,045
| +5,494% | +$16.4M | 0.02% | 755 |
|
|
2015
Q1 | $328K | Sell |
6,663
-15,546
| -70% | -$720K | ﹤0.01% | 1414 |
|
|
2014
Q4 | $1.01M | Buy |
+22,209
| New | +$873K | ﹤0.01% | 1219 |
|
Other funds holding AVNS
AC
Neuberger Berman Group's AVNS Position: Q3 2025 in Review
Neuberger Berman Group sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 22,929 shares — an estimated $281K sold.
Neuberger Berman Group first reported a position in AVNS in Q4 2014 and held it in 30 quarters. The position peaked at $28.5M in Q4 2021. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.
- Neuberger Berman Group reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
- Neuberger Berman Group sold 22,929 Avanos Medical shares in Q3 2025, an estimated $281K.
- Neuberger Berman Group first reported a position in Avanos Medical in Q4 2014 and held it in 30 quarters.
- Neuberger Berman Group's Avanos Medical position peaked at $28.5M in Q4 2021.
- 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.
Based on Neuberger Berman Group's 13F filing for Q3 2025, filed 12 Nov 2025.